Risk-off dynamics accelerate as Chinese coronavirus worsen Risk-off dynamics accelerate as Chinese coronavirus worsen Risk-off dynamics accelerate as Chinese coronavirus worsen

Risk-off dynamics accelerate as Chinese coronavirus worsen

Equities 5 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  Equities in Hong Kong are down almost 3% as the coronavirus in China is worsening impacting real estate, casino and car stocks. With Chinese New Year coming up the situation could get even worse so investors should have this on the radar. In today's equity update we also look at the brewing crisis at Boeing as the company has lost $4bn in free cash flow in two previous quarters and is now negotiation large financing packages with banks. UBS has reported worse than expected Q4 and FY2019 numbers sending shock waves through the European financial sector as it is still bleeding from the ECB's negative interest rate policy.

An unknown virus started small in Wuhan, China, back in mid-December 2019 with the Chinese health authorities later saying that the virus was related to SARS. Initial expectations were muted and human-to-human transmission was not presumed, but yesterday Chinese authorities announced that human-to-human transmission had taken place between patient and health worker. In addition the number of infected people was on rise. The reaction function has been prompt with Hang Seng futures down 2.8% in today’s session led by real estate, casino and car stocks. While we don’t know the direction in equities from here related to the coronavirus, history tells us that there are many unknowns and that the initial reaction often fails to discount the true extent. Short-term this could get much worse for Asian equities as the Chinese New Year means that millions of people will be travelling potentially spreading the virus fast over large areas.

Source: Saxo Group

Boeing crisis could get very ugly

As the grounding of the 737 Max continues the crisis deepens at Boeing with news out yesterday that the company is in talks to secure $10bn financing as the aircraft producer is hemorrhaging cash. In Q3 the company delivered negative $2.9bn in free cash flow (FCF) following negative FCF of $1bn in Q2 and this number could worsen in Q4 which we will know when Q4 earnings are released next Wednesday. Boeing has maintained CAPEX and dividends levels which has forced the company to increase debt to avoid depleting cash reserves. The total debt has risen to $25.9bn in Q3 2019 from $11.9bn in Q3 2018.

Source: Saxo Group

The stock price is down 25% from the peak in March 2019 and is pushing towards dangerous levels that could make many fund managers to reverse their long-term views. Despite the stock is down 25% the enterprise value to total assets ratio is still close to all-time highs reflecting a high degree of confidence in the value of the balance sheet and thus future cash flow generation. If these expectations are shattered next week at the earnings release then the crisis could become severe.

UBS sends a warnings shot to Europe’s banks

UBS shares are down 5% as the bank misses fiscal year profitability and cost targets in addition to trimming its mid-term goals. UBS has been hit by wealth management outflows, negative rates and poor performance in its investment banking division. This obviously sends a warning to investors if they thought overweight European banks was a good idea. Negative rates will continue to haunt European banks until the ECB changes its mind on negative rates.

Source: Saxo Group

Rethink equity valuation on monopolies

Clients are often telling us that equity valuations do not make sense any longer and we observe same phenomenon in public discussions between market participants. But as we argued lately we believe investors have to contemplate the fact that equity valuations could potentially eclipse the levels from the dot-com bubble if rates continue at these low levels and the global economy continues to expand. That mix drives TINA (there is no alternative) behaviour and reprice equities closer to bonds, especially the monopolies with robust cash flows. Is Microsoft really expensive with a free cash flow yield of 3% and revenues growing at 12% y/y given 10-year US Treasuries offer 1.8% with rising deficits and potential inflation?


The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.